Pierre Fabre Limited

Hyde Abbey House, 23 Hyde Street, Winchester, Hampshire, SO23 7DR
Telephone: +44 (0)1962 874 400
Fax: +44 (0)1962 844 014
Medical Information Direct Line: +44 (0)1962 874 435
Medical Information e-mail: medicalinformation@pierre-fabre.co.uk
Customer Care direct line: +44 (0)1962 874 402
Medical Information Fax: +44 (0)1962 874 413

Patient Information Leaflet last updated on the eMC: 12/01/2011
PIL TOPAL chewable tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 12/01/2011 and displayed until Current
Reasons for adding or updating:
  • Change due to harmonisation of PIL.
  • Change to Further Information section
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change of contra-indications
  • Change to storage instructions
  • Change to side-effects
  • Change to drug interactions
  • Change to information about pregnancy or lactation
  • Extra statutory information
  • Change to manufacturer contact details
  • Changes to therapeutic indications
Updated on 24/06/2005 and displayed until 12/01/2011
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but one that is new to the eMC

Active Ingredients/Generics

 
   alginic acid
   magnesium carbonate
   aluminium hydroxide gel, dried